Evaluation of Urine and Vaginal Self-Sampling versus Clinician-Based Sampling for Cervical Cancer Screening: A Field Comparison of the Acceptability of Three Sampling Tests in a Rural Community of Cuenca, Ecuador

被引:4
|
作者
Vega Crespo, Bernardo [1 ]
Alejandra Neira, Vivian [1 ,2 ]
Ortiz, Jose S. [1 ]
Maldonado-Rengel, Ruth [3 ,4 ]
Lopez, Diana [2 ]
Gomez, Andrea [1 ]
Jose Vicuna, Maria [1 ]
Mejia, Jorge [1 ]
Benoy, Ina [5 ]
Parron Carreno, Tesifon [6 ]
Verhoeven, Veronique [7 ]
机构
[1] Univ Cuenca, Fac Ciencias Med, Cuenca 010203, Ecuador
[2] Univ Azuay UDA, Fac Med, Cuenca 010104, Ecuador
[3] Univ Tecn Particular Loja UTPL Loja Ecuador, Fac Ciencias Salud, Loja 1101608, Ecuador
[4] Univ La Frontera UFRO, Programa Doctorado Ciencias Morfol, Temuco 4811230, Chile
[5] Univ Antwerp, Lab Cell Biol & Histol, AMBIOR, B-2610 Antwerp, Belgium
[6] Univ Almeria UAL, Fac Ciencias Salud & Neurociencias, Almeria 04120, Spain
[7] Univ Antwerp, Family Med & Populat Hlth, B-2610 Antwerp, Belgium
关键词
HPV; self-sampling; urine sampling; vaginal sampling; clinician sampling; acceptability; HPV DNA; WOMEN; COVID-19; IMPACT;
D O I
10.3390/healthcare10091614
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Self-sampling methods for HPV testing have been demonstrated to be highly sensitive and specific. The implementation of these methods in settings with a lack of infrastructure or medical attention has been shown to increase the coverage of cervical cancer screening and detect cervical abnormalities in the early stages. The aim of this study is to compare the acceptability of urine and vaginal self-sampling methods versus clinician sampling among rural women. A total of 120 women participated. Each participant self-collected urine and vaginal samples and underwent clinician sampling for Pap smear and HPV testing. After the sample collection, a questionnaire to qualify the device, technique, and individual acceptability was applied, and the additional overall preference of three sample tests was evaluated. Results: The characteristics of the participants were as follows: median age of 35 years; 40.8% were married; 46.7% had a primary level of education; median age of sexual onset of 17.6 years. Compared with clinician sampling, both vaginal self-sampling, OR 20.12 (7.67-52.8), and urine sampling, OR 16.63 (6.79-40.72), were more comfortable; granted more privacy: vaginal self-sampling, OR 8.07 (3.44-18.93), and urine sampling, OR 19.5 (5.83-65.21); were less painful: vaginal self-sampling, OR 0.07 (0.03-0.16), and urine sampling, OR 0.01 (0-0.06); were less difficult to apply: vaginal self-sampling, OR 0.16 (0.07-0.34), and urine sampling, OR 0.05 (0.01-0.17). The overall preference has shown an advantage for vaginal self-sampling, OR 4.97 (2.71-9.12). No statistically significant preference was demonstrated with urine self-sampling versus clinician sampling. Conclusions: Self-sampling methods have a high acceptance in rural communities. Doubts on the reliability of self-sampling often appear to be a limitation on its acceptability. However, the training and education of the community could increase the uptake of these methods.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Acceptability of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening in a Cohort of Patients from Romania (Stage 2)
    Grigore, Mihaela
    Vasilache, Ingrid-Andrada
    Cianga, Petru
    Constantinescu, Daniela
    Duma, Odetta
    Matasariu, Roxana Daniela
    Scripcariu, Ioana-Sadiye
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (09)
  • [32] HPV self-sampling among cervical cancer screening users in Spain: A randomized clinical trial of on-site training to increase the acceptability
    Ibanez, Raquel
    Roura, Esther
    Acera, Amelia
    Andujar, Miguel
    Pavon, Miquel Angel
    Bruni, Laia
    de Sanjose, Silvia
    PREVENTIVE MEDICINE, 2023, 173
  • [33] Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria
    Fatima Modibbo
    K. C. Iregbu
    James Okuma
    Annemiek Leeman
    Annemieke Kasius
    Maurits de Koning
    Wim Quint
    Clement Adebamowo
    Infectious Agents and Cancer, 12
  • [34] Feasibility and applicability of self-sampling based online cervical cancer screening: findings from the China online cervical cancer screening trial
    Zhang, Yi
    Du, Hui
    Wang, Chun
    Huang, Xia
    Qu, Xinfeng
    Wu, Ruifang
    INFECTIOUS AGENTS AND CANCER, 2024, 19 (01)
  • [35] Age-related acceptability of vaginal self-sampling in cervical cancer screening at two university hospitals: a pilot cross-sectional study
    Cristina Lorenz, Noely Paula
    Termini, Lara
    Longatto Filho, Adhemar
    Tacla, Maricy
    de Aguiar, Lana Maria
    Beldi, Mariana Carmezim
    Ferreira-Filho, Edson Santos
    Baracat, Edmund Chada
    Soares-Junior, Jose Maria
    BMC PUBLIC HEALTH, 2019, 19 (1) : 963
  • [36] Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening
    Meenan, Richard T.
    Troja, Catherine
    Buist, Diana S. M.
    Tiro, Jasmin A.
    Lin, John
    Anderson, Melissa L.
    Gao, Hongyuan
    Green, Beverly B.
    Winer, Rachel L.
    JAMA NETWORK OPEN, 2023, 6 (03) : E234052
  • [37] Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in E1 Salvador
    Maza, M.
    Melendez, M.
    Masch, R.
    Alfaro, K.
    Chacon, A.
    Gonzalez, E.
    Soler, M.
    Conzuelo-Rodriguez, G.
    Gage, J. C.
    Alonzo, T. A.
    Castle, P. E.
    Felix, J. C.
    Cremer, M.
    PREVENTIVE MEDICINE, 2018, 114 : 149 - 155
  • [38] A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador
    Laskow, Bari
    Figueroa, Ruben
    Alfaro, Karla M.
    Scarinci, Isabel C.
    Conlisk, Elizabeth
    Maza, Mauricio
    Chang, Judy C.
    Cremer, Miriam
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2017, 138 (02) : 194 - 200
  • [39] Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial
    Haguenoer, K.
    Sengchanh, S.
    Gaudy-Graffin, C.
    Boyard, J.
    Fontenay, R.
    Marret, H.
    Goudeau, A.
    de Laroche, N. Pigneaux
    Rusch, E.
    Giraudeau, B.
    BRITISH JOURNAL OF CANCER, 2014, 111 (11) : 2187 - 2196
  • [40] Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial
    Fujita, Misuzu
    Nagashima, Kengo
    Shimazu, Minobu
    Suzuki, Misae
    Tauchi, Ichiro
    Sakuma, Miwa
    Yamamoto, Setsuko
    Hanaoka, Hideki
    Shozu, Makio
    Tsuruoka, Nobuhide
    Kasai, Tokuzo
    Hata, Akira
    PLOS ONE, 2023, 18 (06):